A decrease in the number of circulating platelets.
A condition when the bone marrow does not produce enough platelets (thrombocytes) like in leukaemia.
A decrease in the number of platelets in the blood leading to bleeding in the mouth and scattered bruises. This condition is sometimes caused by certain anticonvulsant medications (mood stabilizers), such as carbamazepine and valproate, as well as by antipsychotics such as clozapine.
Condition in which there is an abnormally small number of platelets in circulating blood.
Reduced number of thrombocytes (platelets).
A condition in which someone has an unusually low number of platelets in the blood.
Deficiency of thrombocytes due to action or chemicals or drugs that damage stem cells in the bone marrow; also occurs when leukemia cells take over and crowd the stem cells that produce thrombocytes.
A shortage of platelets, blood cells that have a key role in clotting. Symptoms include profuse blood loss after injury or surgery, a measleslike rash known as purpura (usually on the lower legs), nosebleeds, swollen joints, blood in vomit or feces, and heavy menstrual flow. Widespread bleeding, particularly in the digestive system or brain, can be life-threatening.
A reduction in the number of platelets in the blood. This results in bleeding into the skin, spontaneous bruising, and prolonged bleeding after injury. Thrombocytopenia may result from failure of platelet production or excessive destruction of platelets.
A fall in the number of platelets (thrombocytes) in the blood caused by failure of production, or excessive destruction, of platelets. The result is bleeding into the skin (purpura), serious bleeding after injury and spontaneous bruising.
A pathological decrease in the quantity of platelets circulating within the bloodstream.
A decrease in the quantity of platelets (the smallest type of blood cell) within the bloodstream. Because platelets are crucial for blood clotting, thrombocytopenia leads to an increased susceptibility to bleeding, particularly from smaller blood vessels. Thrombocytopenic purpura, characterized by unusual bleeding into the skin, can occasionally arise as a result.
Thrombocytopenia can stem from either a diminished rate of platelet production or an accelerated rate of platelet breakdown. This condition can be associated with various illnesses, including leukemia, lymphoma, systemic lupus erythematosus, megaloblastic anemia, and hypersplenism. Thrombocytopenia may also be triggered by viral infections, exposure to radiation, or an adverse reaction to prescribed medications like thiazide diuretics. Idiopathic thrombocytopenic purpura (ITP) is an example of an autoimmune disorder.
Thrombocytopenia is diagnosed through a blood count. If an underlying condition is identified, it is addressed accordingly. In cases of ITP in children, treatment might not be necessary, while adults are often prescribed corticosteroid medications. If thrombocytopenia persists, splenectomy (spleen removal) might be considered. Once the cause is determined, treatment typically leads to an elevation in platelet levels.